Enforcement record

締結 disclosure naming スウェーデン医薬品庁

スウェーデン医薬品庁 (薬事規制に関する守秘取り決め)

This page records one action from a Japanese government disclosure, including the published name, governing law, authority, action details, and official source.

薬事規制に関する守秘取り決めMinistry of Health, Labour and WelfareGovernment disclosure28 June 2017

Action type

締結

Law

薬事規制に関する守秘取り決め

Authority

Ministry of Health, Labour and Welfare

Action date

28 June 2017

RegBase evidence report

Japanese public-record enforcement check

Saveable record of the published action, regulator source, source status, and review notes for internal compliance files.

Report ID: RB-EN-ENFORCEMENT-OTHER-SUUEDENYI-Y-202608041951
Generated at: 5 August 2026 at 04:51
Record URL: https://regbase.jp/en/enforcement/other-suuedenyi-yao-pin-ting-20170628

1. Review Summary

Disclosure name	スウェーデン医薬品庁	Corporate Number	Not stated in the disclosure
Enforcement record	1 record	Other confirmed records for this company	Outside this report's scope
Action date	28 June 2017	Authority	Ministry of Health, Labour and Welfare
Law	薬事規制に関する守秘取り決め	Action type	締結
Source status	Preserved public-source archive recorded

This report summarizes public Japanese government disclosure data held by RegBase. It is not a credit score, sanctions conclusion, legal opinion, or adverse-media determination. Confirm important decisions against the linked official Japanese source.

2. Published Information

Published name	スウェーデン医薬品庁

3. Enforcement Record

Target name in disclosure	スウェーデン医薬品庁
Authority	Ministry of Health, Labour and Welfare (厚生労働省)
Law / action type	薬事規制に関する守秘取り決め / 締結
Action / announcement date	Action: 28 June 2017 / Announcement: 6 April 2026
English summary	Signed a confidentiality agreement concerning pharmaceutical regulations to facilitate information exchange related to the development and review of innovative pharmaceuticals, post-marketing safety measures, patient registration, and to promote smooth communication and cooperation.
Original Japanese text	薬事規制に関する守秘取り決めを締結し、革新的な医薬品の開発・審査情報の交換や市販後安全対策に係る患者登録等について情報交換の円滑化、協力の進展を目的とした。
Official source	https://www.mhlw.go.jp/stf/houdou/0000170062.html
Source archive	https://kiroku.today/a/287dbc8b23hg2vih
Extraction / evidence timestamps	Extracted: 25 April 2026 at 09:11 / Evidence checked: 25 April 2026 at 09:11 / Archive captured: 12 July 2026 at 16:02

4. Business Location and Permit Details

No additional structured business-location or permit fields are recorded for this disclosure.

5. Other Confirmed Records for This Company

This report covers the single government disclosure shown on this page.

Reviewer Notes

Reviewer		Team / company
Review purpose
Additional notes

□ Official source URL or archived source was checked.
□ Corporate Number, address, or other identifiers were reviewed to avoid confusing similarly named entities.
□ This document is understood as a public-record evidence file, not a credit decision or legal opinion.

Current page: Enforcement record

This screen focuses on one disclosed action: the published name, governing law, authority, facts, source status, and review evidence.

Free report

Save the disclosure record naming スウェーデン医薬品庁

Includes the published name, regulator, governing law, source links, archive status, and reviewer note fields for internal due-diligence files.

Preserved evidence by Kiroku

Review the preserved source for スウェーデン医薬品庁

Open the preserved public source with its capture time, original artifact, available verification data, and downloadable evidence pack.

Open preserved source and evidence pack

For developers: JSON integration details

You do not need this for normal browsing. Use it only when integrating this enforcement record into an internal tool or AI workflow.

/api/v1/enforcements?company=%E3%82%B9%E3%82%A6%E3%82%A7%E3%83%BC%E3%83%87%E3%83%B3%E5%8C%BB%E8%96%AC%E5%93%81%E5%BA%81&limit=10

Open JSON Specs

Action summary

Company: スウェーデン医薬品庁Japanese only
Original: スウェーデン医薬品庁
Governing law: 薬事規制に関する守秘取り決め
薬事規制に関する守秘取り決め
Action type: 締結
締結
Action date: 28 June 2017
Issuing authority: Ministry of Health, Labour and Welfare
厚生労働省
Industry context: 医薬品規制

Violation

Machine-translated summary — verify against original

Signed a confidentiality agreement concerning pharmaceutical regulations to facilitate information exchange related to the development and review of innovative pharmaceuticals, post-marketing safety measures, patient registration, and to promote smooth communication and cooperation.

Show original Japanese text

薬事規制に関する守秘取り決めを締結し、革新的な医薬品の開発・審査情報の交換や市販後安全対策に係る患者登録等について情報交換の円滑化、協力の進展を目的とした。

Compliance context

Context needed

This is a public Japanese regulatory disclosure. The exact legal effect depends on the cited source and regulator.

Japanese regulatory disclosure under 薬事規制に関する守秘取り決め.

Review the original Japanese source and determine relevance to your counterparty-risk workflow.

This context is an operational aid for review workflows, not a credit opinion or legal conclusion.

Evidence pack

Original Ministry of Health, Labour and Welfare source (Japanese)Open preserved source and evidence pack

Extracted at: 2026-04-25T00:11:28.171+00:00
Evidence checked: 2026-04-25T00:11:28.171+00:00
Archive captured: 2026-07-12T07:02:41.62388+00:00

Show audit JSON

{
  "record": {
    "id": "2b71a9f6-e786-4f65-ad38-ffe0854e37ae",
    "url": "https://regbase.jp/en/enforcement/other-suuedenyi-yao-pin-ting-20170628",
    "company_name_original": "スウェーデン医薬品庁",
    "company_name_registry": null,
    "corporate_number": null,
    "law": {
      "ja": "薬事規制に関する守秘取り決め",
      "en": "薬事規制に関する守秘取り決め"
    },
    "action_type": {
      "ja": "締結",
      "en": "締結"
    },
    "authority": {
      "ja": "厚生労働省",
      "en": "Ministry of Health, Labour and Welfare"
    }
  },
  "entity_match": {
    "status": "unresolved",
    "confidence": 60,
    "method": "extracted_japanese_name",
    "method_label": "Company name extracted from the Japanese public disclosure",
    "notes": "The linked company profile has not been verified under the current identity policy."
  },
  "review": {
    "status": "unreviewed",
    "label": "Machine extracted"
  },
  "compliance_context": {
    "severity": "Context needed",
    "actionMeaning": "This is a public Japanese regulatory disclosure. The exact legal effect depends on the cited source and regulator.",
    "practicalNote": "Review the original Japanese source and determine relevance to your counterparty-risk workflow.",
    "lawContext": "Japanese regulatory disclosure under 薬事規制に関する守秘取り決め."
  },
  "evidence": {
    "recordUrl": "https://regbase.jp/en/enforcement/other-suuedenyi-yao-pin-ting-20170628",
    "officialSourceUrl": "https://www.mhlw.go.jp/stf/houdou/0000170062.html",
    "officialDocumentUrl": null,
    "archiveUrl": "https://kiroku.today/a/287dbc8b23hg2vih",
    "archivedSourceUrl": "https://www.mhlw.go.jp/stf/houdou/0000170062.html",
    "archiveCapturedAt": "2026-07-12T07:02:41.62388+00:00",
    "extractedAt": "2026-04-25T00:11:28.171+00:00",
    "translatedAt": "2026-05-01T07:01:25.995+00:00",
    "evidenceCheckedAt": "2026-04-25T00:11:28.171+00:00",
    "generatedAt": "2026-08-04T19:51:35.150Z"
  },
  "limitations": [
    "RegBase aggregates public Japanese government disclosures and does not provide a credit opinion.",
    "English summaries are provided for reference. The original Japanese source is authoritative.",
    "Possible or unresolved entity matches should be manually verified before use in a decision."
  ]
}

The original Japanese disclosure is the authoritative record. Use possible or unresolved matches only as leads for manual review.

Language

日本語版を見る (Japanese)

About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.